Chemokines and graft-versus-host disease - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 417

[59] Murphy WJ, Wang Z, Welniak LA, Kuziel W, Blazar BR. T cells from CCR5 knockout mice
induce accelerated acute graft-versus-host disease lethality after allogeneic BMT in
mice. Biol Blood Marrow Transplant 2002;8:66-7.
[60] Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, et al.
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease
based on pretransplant conditioning. J Immunol 2004;173:845-54.
[61] Palmer LA, Sale GE, Balogun JI, Li D, Jones D, Molldrem JJ, et al. Chemokine receptor
CCR5 mediates alloimmune responses in graft-versus-host disease. Biol Blood Marrow
Transplant 2010;16:311-9.
[62] Shahin K, Sartor M, Hart D, Bradstock K. Upregulation of the chemokine receptor CCR5
and CD16+ myeloid blood dendritic cells in allogeneic hemopoietic cell transplanta-
tion patients predicts for acute graft versus host disease. Blood 2011;118:865.
[63] Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C, et al. Donor T-cell
production of RANTES significantly contributes to the development of idiopathic pneu-
monia syndrome after allogeneic stem cell transplantation. Blood 2005;105:2249-57.
[64] Gao W, Topham PS, King JA, Smiley ST, Csizmadia V, Lu B, et al. Targeting of the chemo-
kine receptor CCR1 suppresses development of acute and chronic cardiac allograft
rejection. J Clin Invest 2000;105:35-44.
[65] Horuk R, Clayberger C, Krensky AM, Wang Z, Grone HJ, Weber C, et al. A non-peptide
functional antagonist of the CCR1 chemokine receptor is effective in rat heart trans-
plant rejection. J Biol Chem 2001;276:4199-204.
[66] Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, et al. The
CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects
from graft-versus-host disease but does not modify graft-versus-leukemia in mice.
J Immunol 2010;184:2646-54.
[67] Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, et al. Severe reduction
in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine
receptor 2. Proc Natl Acad Sci U S A 1997;94:12053-8.
[68] Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary,
effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
[69] Peters W, Dupuis M, Charo IF. A mechanism for the impaired IFN-gamma production
in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate
and adaptive immune responses. J Immunol 2000;165:7072-7.
[70] Kurihara T, Bravo R. Cloning and functional expression of mCCR2, a murine receptor
for the C-C chemokines JE and FIC. J Biol Chem 1996;271:11603-7.
[71] Belperio JA, Keane MP, Burdick MD, Lynch 3rd JP, Xue YY, Berlin A, et al. Critical role
for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syn-
drome. J Clin Invest 2001;108:547-56.
[72] Hildebrandt GC, Duffner UA, Olkiewicz KM, Corrion LA, Willmarth NE, Williams
DL, et al. A critical role for CCR2/MCP-1 interactions in the development of idio-
pathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood
2004;103:2417-26.
[73] Ambruzova Z, Mrazek F, Raida L, Jindra P, Vidan-Jeras B, Faber E, et al. Association of
IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic
stem cell transplantation. Bone Marrow Transplant 2009;44:227-35.
[74] Tekamp-Olson P, Gallegos C, Bauer D, McClain J, Sherry B, Fabre M, et al. Cloning and
characterization of cDNAs for murine macrophage inflammatory protein 2 and its
human homologues. J Exp Med 1990;172:911-9.
[75] Rovai LE, Herschman HR, Smith JB. The murine neutrophil-chemoattractant chemo-
kines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and
tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukocyte
Biol 1998;64:494-502.
[76] Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two
high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-7.
[77] Lee J, Cacalano G, Camerato T, Toy K, Moore MW, Wood WI. Chemokine binding and
activities mediated by the mouse IL-8 receptor. J Immunol 1995;155:2158-64.
[78] Hancock WW, Gao W, Faia KL, Csizmadia V. Chemokines and their receptors in al-
lograft rejection. Curr Opin Immunol 2000;12:511-6.
[79] Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, et al. Early che-
mokine cascades in murine cardiac grafts regulate T cell recruitment and progression
of acute allograft rejection. J Immunol 2001;167:2979-84.
[80] Elssner A, Vogelmeier C. The role of neutrophils in the pathogenesis of obliterative
bronchiolitis after lung transplantation. Transplant Infect Dis 2001;3:168-76.
[81] Panoskaltsis-Mortari A, Tram KV, Price AP, Wendt CH, Blazar BR. A new murine model
for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med
2007;176:713-23.

422